These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 28865379)

  • 1. Quantitative sensory tests (QST) are promising tests for clinical relevance of anti-nociceptive effects of new analgesic treatments.
    Jääskeläinen SK
    Scand J Pain; 2017 Oct; 17():144-145. PubMed ID: 28865379
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Arendt-Nielsen L; Curatolo M
    Scand J Pain; 2017 Oct; 17():107-115. PubMed ID: 28850362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting drug efficacy in chronic low back pain by quantitative sensory tests.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Stamer U; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2018 May; 22(5):973-988. PubMed ID: 29363217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects.
    Eisenberg E; Midbari A; Haddad M; Pud D
    Pain; 2010 Oct; 151(1):104-109. PubMed ID: 20621419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can quantitative sensory testing predict responses to analgesic treatment?
    Grosen K; Fischer IW; Olesen AE; Drewes AM
    Eur J Pain; 2013 Oct; 17(9):1267-80. PubMed ID: 23658120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
    Siegenthaler A; Schliessbach J; Vuilleumier PH; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    BMC Pharmacol Toxicol; 2015 Sep; 16():23. PubMed ID: 26376691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers.
    Cooper ZD; Johnson KW; Vosburg SK; Sullivan MA; Manubay J; Martinez D; Jones JD; Saccone PA; Comer SD
    Drug Alcohol Depend; 2017 Sep; 178():340-347. PubMed ID: 28688296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does long-term opioid therapy reduce pain sensitivity of patients with chronic low back pain? Evidence from quantitative sensory testing.
    Wang H; Fischer C; Chen G; Weinsheimer N; Gantz S; Schiltenwolf M
    Pain Physician; 2012 Jul; 15(3 Suppl):ES135-43. PubMed ID: 22786452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of single-dose imipramine on chronic low-back and experimental pain. A randomized controlled trial.
    Schliessbach J; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Vuilleumier PH; Stamer U; Arendt-Nielsen L; Curatolo M
    PLoS One; 2018; 13(5):e0195776. PubMed ID: 29742109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between sensitisation and pain-related behaviours in an experimental canine model of osteoarthritis.
    Rialland P; Otis C; Moreau M; Pelletier JP; Martel-Pelletier J; Beaudry F; Del Castillo JR; Bertaim T; Gauvin D; Troncy E
    Pain; 2014 Oct; 155(10):2071-9. PubMed ID: 25075591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial and novel mathematical analysis of the analgesic effect of oxycodone versus paracetamol orodispersible tablets.
    Martini CH; Proto P; Olofsen E; van Velzen M; Aarts L; Dahan A; Niesters M
    Eur J Pain; 2015 Mar; 19(3):295-304. PubMed ID: 24947675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of static and dynamic quantitative sensory testing in patients with painful chronic pancreatitis.
    Olesen SS; van Goor H; Bouwense SA; Wilder-Smith OH; Drewes AM
    Reg Anesth Pain Med; 2012; 37(5):530-6. PubMed ID: 22854397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative sensory characteristics of the lateral femoral cutaneous nerve after mepivacaine-induced block.
    Menzer C; Schley M; Rukwied R; Schmelz M; Dusch M; Benrath J
    Scand J Pain; 2013 Apr; 4(2):95-100. PubMed ID: 29913895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxycodone alters temporal summation but not conditioned pain modulation: preclinical findings and possible relations to mechanisms of opioid analgesia.
    Suzan E; Midbari A; Treister R; Haddad M; Pud D; Eisenberg E
    Pain; 2013 Aug; 154(8):1413-8. PubMed ID: 23707271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect.
    Edwards RR; Dolman AJ; Michna E; Katz JN; Nedeljkovic SS; Janfaza D; Isaac Z; Martel MO; Jamison RN; Wasan AD
    Pain Med; 2016 Oct; 17(10):1882-1891. PubMed ID: 26933094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
    Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
    J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of postoperative opioid analgesia using clinical-experimental parameters and electroencephalography.
    Gram M; Erlenwein J; Petzke F; Falla D; Przemeck M; Emons MI; Reuster M; Olesen SS; Drewes AM
    Eur J Pain; 2017 Feb; 21(2):264-277. PubMed ID: 27470494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism.
    Zwisler ST; Enggaard TP; Noehr-Jensen L; Pedersen RS; Mikkelsen S; Nielsen F; Brosen K; Sindrup SH
    Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):335-44. PubMed ID: 19281600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II, Randomized, Double-Blind, Placebo Controlled, Dose-Response Trial of the Melatonin Effect on the Pain Threshold of Healthy Subjects.
    Stefani LC; Muller S; Torres IL; Razzolini B; Rozisky JR; Fregni F; Markus R; Caumo W
    PLoS One; 2013; 8(10):e74107. PubMed ID: 25947930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.